The number of federally-approved opioid treatment programs, which are qualified to dispense methadone and buprenorphine for opioid use disorders, increased 39% between 2003 and 2016, according to a new report by the Substance Abuse and Mental Health Services Administration. About 10% of all substance use treatment facilities had OTPs in 2015.